PE/Cyanine5 Anti-Human CD11a Antibody[R7-1]

PE/Cyanine5 Anti-Human CD11a Antibody[R7-1]

Introducing the PE/Cyanine5 Anti-Human CD11a Antibody [R7-1], a highly advanced and meticulously developed product designed to cater to the specific needs of the scientific community. This antibody, meticulously crafted using cutting-edge technology, offers unparalleled precision and accuracy in the field of immunology research.

The PE/Cyanine5 Anti-Human CD11a Antibody [R7-1] is specifically engineered to target the CD11a protein, a crucial component of the integrin family involved in cell adhesion and migration. With its exceptional specificity and affinity, this antibody enables researchers to explore and elucidate the intricate mechanisms underlying immune responses and cellular interactions.

This product boasts an exceptional level of quality, ensuring reproducibility and reliability in experimental results. Its superior performance is attributed to the rigorous validation process it undergoes, guaranteeing optimal functionality and consistency across various applications, including flow cytometry and immunofluorescence.

The PE/Cyanine5 Anti-Human CD11a Antibody [R7-1] exhibits exceptional sensitivity, allowing for the detection of even low expression levels of CD11a on human cells. Its remarkable fluorescence properties, combined with its high signal-to-noise ratio, enable precise and accurate identification and quantification of CD11a-positive cells.

Furthermore, this antibody is manufactured in strict compliance with the highest industry standards, ensuring the utmost purity and stability. Its long shelf life and robust formulation make it an ideal choice for long-term storage and repeated use, minimizing the need for frequent reordering.

In summary, the PE/Cyanine5 Anti-Human CD11a Antibody [R7-1] represents a pinnacle of scientific innovation, offering researchers an invaluable tool to unravel the complexities of immune responses and cellular interactions. With its exceptional specificity, sensitivity, and reliability, this antibody is poised to revolutionize the field of immunology research.